Beyond the Basics: The Art and Science of Strip Interpretation - - PowerPoint PPT Presentation

▶
beyond the basics the art and science of strip
SMART_READER_LITE
LIVE PREVIEW

Beyond the Basics: The Art and Science of Strip Interpretation - - PowerPoint PPT Presentation

Mar 19, 2023 16 likes •638 views

2014 Fetal Monitoring Lunch & Learn Series Beyond the Basics: The Art and Science of Strip Interpretation Session 5: December 10, 2014 1 Wisconsin Association for Perinatal Care (WAPC) 2 Faculty Chris Van Mullem, RNC, MS Clinical

slide-1
SLIDE 1

Session 5:

December 10, 2014

Beyond the Basics: The Art and Science of Strip Interpretation

2014 Fetal Monitoring Lunch & Learn Series

1

slide-2
SLIDE 2

Wisconsin Association for Perinatal Care (WAPC)

2

slide-3
SLIDE 3

Faculty

  • Chris Van Mullem, RNC, MS

Clinical Nurse Specialist Aurora Sinai Hospital Milwaukee, WI

3

slide-4
SLIDE 4

Notice of Disclosures

  • Notice of requirements for successful completion

– Registrants must attend full session and complete evaluation to receive contact hours

  • Conflicts of Interest

– None to report

  • Financial Disclosures

– None

  • Sponsorship or commercial support

– None

  • Non-endorsement of products

– The speaker does not endorse the use of any particular medications or products as part of this educational session

  • Off-label use

– The speaker may discuss the off-label use of misoprostol and terbutaline as they relate to labor and delivery.

  • Expiration date for awarding contact hours

– 12/31/2014

4

slide-5
SLIDE 5

Before we begin…

  • Listen-only mode
  • Questions – please ask, please answer!

– Raise your hand – Type into the Question Pane – Out of time? Email wapc@perinatalweb.org

  • Technical problems: Email Barb Wienholtz

at wienholtz@perinatalweb.org

5

slide-6
SLIDE 6

Before we begin…

The content presented today is a case study. Components of this case were chosen based on their applicability to achieve learning objectives for this presentation. Do not assume the patient featured in the case was cared for by the instructor or at the facility at which the instructor is employed. The discussion will focus on interpretation of the electronic fetal monitoring (EFM) tracings for the purpose of education. At times, the discussion may lead to the care decisions made based on EFM interpretation. IF the instructor shares details regarding actual or potential care decisions, please note those decisions do not necessarily reflect the opinions of the instructor, a particular provider, the standard of care for any particular institution or facility, or of WAPC.

6

slide-7
SLIDE 7

Objectives

At the conclusion of the session, participants will be able to:

  • 1. Systematically review the electronic fetal monitor strip
  • 2. Identify and categorize the FHR pattern
  • 3. Identify and discuss uterine activity patterns and their influence on the FHR

baseline

  • 4. Discuss the pathophysiology related to the tracing patterns identified
  • 5. Discuss interventions for management and documentation of intrapartum

fetal heart rate tracings

7

slide-8
SLIDE 8

2008 NICHD Report

The 2008 National Institute of Child Health and Human Development (NICHD) Report of Fetal Heart Rate Monitoring

  • Defined standard fetal heart rate

nomenclature

  • Identified three categories for fetal heart

rate interpretation

  • Proposed future research

8

slide-9
SLIDE 9

2008 NICHD Report

  • Report endorsed by:

– ACOG (2009) Practice Bulletin #106 "Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation and General Management Principles” – AWHONN-endorsed and incorporated in fetal monitoring curriculum – American College of Nurse Midwives – American Academy of Family Practice

American College of Obstetricians and Gynecologists (2009, July). ACOG Practice Bulletin #106: Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation, and General Management Principles. Washington, D.C.: Author

9

slide-10
SLIDE 10

ACOG Practice Bulletin #116 (2010)

"Management of Intrapartum Fetal Heart Rate Tracings"

  • Reviewed:

– Nomenclature – Fetal Heart Rate Interpretation (categories)

  • Provided framework for evaluation and management of intrapartum patterns

based on categories

  • Assessment algorithm for fetal heart rate patterns
  • Intrapartum resuscitative measures
  • Management of uterine tachysystole

American College of Obstetricians and Gynecologists (2009, July). ACOG Practice Bulletin #106: Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation, and General Management Principles. Washington, D.C.: Author

10

slide-11
SLIDE 11

Systematic Review of Case Studies

The following questions are used to evaluate every tracing, followed by specific questions: 1. What is the contraction pattern? (interval, duration, resting tone if appropriate) 2. What is the baseline fetal heart rate? 3. What is the baseline variability? 4. Are there any periodic changes present? 5. Are there any episodic changes present? 6. What are the probable causes of the changes present? 7. When was the last reassuring sign of fetal well-being?

11

slide-12
SLIDE 12

Strip Review Discussion

  • Interpretation
  • Interventions/Communication
  • Documentation in chart

12

slide-13
SLIDE 13

Intervention/Communication

  • SBAR

– Situation – Background – Assessment – Recommendation

13

slide-14
SLIDE 14

History

Patient is a 24 year old G5P2022 female at 23w1d with EDD of 11/18/2014 by US done today who initially presented to triage with complaint of lower abdominal cramping. No prenatal care. FHR were unable to trace, so US was obtained showing fetal tachycardia to 210-240bpm with infrequent baseline rate of 110. Breech, AC 47%, EFW 561 g, (39%), BPP 6/8 Patient reports + fetal movements Patient history not contributory. BP 100/54. P 79, BMI 19.97, Spo2 98% She was admitted for observation to L&D.

slide-15
SLIDE 15

Poll question

  • Q1. The most common cause of fetal tachyarrhythmia is:
  • a. Supraventricular tachycardia
  • b. Sinus tachycardia
  • c. Atrial flutter/atrial fibrillation
slide-16
SLIDE 16

Poll question

  • Q2. The preferred method for monitoring the fetal

heart rate in the presence of a fetal arrhythmia is:

  • a. Fetal scalp electrode
  • b. External monitoring
  • c. Auscultation
slide-17
SLIDE 17

Poll question

  • Q3. The ultrasound transducer may half-count an

elevated fetal heart rate of more than 180 bpm.

  • a. True
  • b. False
slide-18
SLIDE 18

Tracing 1

slide-19
SLIDE 19

Tracing 2

slide-20
SLIDE 20

Tracing 3

slide-21
SLIDE 21

Tracing 4

slide-22
SLIDE 22

Supraventricular Tachycardia

SVT

  • Sustained, rapid regular atrial

arrhythmia.

  • Rate may range from 210-320 bpm.

Typical-240-260

slide-23
SLIDE 23

Mechanisms of SVT

  • Increased automaticity of

ectopic pacemaker above bundle of HIS

  • Reentrant tachycardia (circular)

most commonly within AV node

slide-24
SLIDE 24

Evaluation of SVT

  • Ultrasound
  • Pulsed wave Doppler
  • Fetal Echocardiogram
  • Fetal Magnetocardiography
  • M-Mode EchoCG
  • External fetal heart rate monitoring
slide-25
SLIDE 25

SVT

  • Increases the workload of the fetal heart
  • Increases oxygen demand

Effect:

  • depending on gestational age of fetus and persistence of SVT
  • CHF (pericardial or pleural effusion, cariomegaly,

polyhydramios, scalp edema, ascites

  • Hemolysis of red blood cells
  • Development of non-immune hydrops fetalis and fetal death
slide-26
SLIDE 26

Treatment

slide-27
SLIDE 27

Maternal Assessment

  • Medical history especially cardiac
  • Medication History
  • ECG
  • Blood pressure
  • Labs (electrolytes, renal and hepatic

function, urine protein, platelet function)

slide-28
SLIDE 28

Drug Treatment

slide-29
SLIDE 29

Tracing 5

29

slide-30
SLIDE 30

Tracing 6

30

slide-31
SLIDE 31

Tracing 7

31

slide-32
SLIDE 32

Tracing 8

32

slide-33
SLIDE 33

Tracing 9

33

slide-34
SLIDE 34

Tracing 10

34

slide-35
SLIDE 35

35

Absence of conduction of the impulse from SA node through AV node

Causes:

  • Cardiac structural defects,
  • CMV,
  • anti-phospholipid syndrome,
  • maternal antibodies

Treatment:

  • Steroids
  • Increase fetal heart rate (terbutaline)
  • Close monitoring
  • Fetal movement counting
  • Real time US to assess for decompensation

Heart Block

slide-36
SLIDE 36

Tracing 11

36

slide-37
SLIDE 37

Tracing 12

37

slide-38
SLIDE 38

Tracing 13

38

slide-39
SLIDE 39

Tracing 14

slide-40
SLIDE 40

Tracing 15

slide-41
SLIDE 41

Tracing 16

41

slide-42
SLIDE 42

Tracing 17

42

slide-43
SLIDE 43

Tracing 18

43

slide-44
SLIDE 44

Tracing 19

44

slide-45
SLIDE 45

Tracing 20

45

slide-46
SLIDE 46

Tracing 21

46

slide-47
SLIDE 47

Tracing 22

47

slide-48
SLIDE 48

Tracing 23

48

slide-49
SLIDE 49

Tracing 24

49

slide-50
SLIDE 50

Tracing 25

50

slide-51
SLIDE 51

Tracing 26

51

slide-52
SLIDE 52

Tracing 27

52

slide-53
SLIDE 53

Tracing 28

53

slide-54
SLIDE 54

Tracing 29

54

slide-55
SLIDE 55

Tracing 30

55

slide-56
SLIDE 56

Tracing 31

56

slide-57
SLIDE 57

Tracing 32

57

slide-58
SLIDE 58

Tracing 33

58

slide-59
SLIDE 59

Outcome

  • AROM/meconium
  • FSE/IUPC
  • Vaginal forceps delivery
  • Male
  • 8 1, , 9 5
  • pH 7.34
  • 5# 10.5 oz
  • EKG and Echo normal
slide-60
SLIDE 60

Discussion

Questions? Comments?

60

slide-61
SLIDE 61

Remember

  • Fax or email attendance list to WAPC

– fax: 608-285-5004 – email: wapc@perinatalweb.org

  • Evaluation will be sent via email from WAPC. Please

complete to receive Continuing Education Credit.

  • Continuing Education Certificate will be sent via email

upon completion of evaluation.

  • Become a member of WAPC! Join online:

https://www.perinatalweb.org/n- pay/membership.asp

  • Save the date for the 2015 WAPC Annual Perinatal

Conference April 26-28, 2015, in Appleton.

61

slide-62
SLIDE 62

62

Thank you!